MENAA-GMPS-NÖROM Joint Webinar
CGRP-targeted migraine treatment: real-world evidence and the pipeline
The live stream will start here
20:00 Türkiye (GMT+3)19:00 Spain (GMT+2)20:00 Egypt (GMT+3)19:00 Denmark (GMT+2)
Keep this page open — the player appears automatically when the broadcast begins.
A free online joint webinar of MENAA, the Global Migraine and Pain Society (GMPS) and NÖROM on CGRP-targeted migraine treatment — real-world evidence on monoclonal antibodies and CGRP antagonists, and the drugs in the pipeline — with speakers from Spain, Egypt and Denmark and live Q&A.
- Date
- Tuesday, 20 October 2026
- Start time
- 20:00Türkiye (GMT+3)19:00Spain (GMT+2)20:00Egypt (GMT+3)19:00Denmark (GMT+2)
- Where
- Live stream on this page · free
- Language
- English
Programme
Moderated by Esme Ekizoğlu Turgut and Doğa Vuralli.
Talk 1
Real-World Evidence on the Efficacy and Safety of CGRP Monoclonal Antibodies
Margarita Sánchez del Río
Department of Neurology, Clínica Universidad de Navarra, Madrid, Spain
Talk 2
Real-World Evidence on the Efficacy and Safety of CGRP Antagonists
Amr Hassan
Cairo University, Department of Neurology, Egypt
Talk 3
Drugs in the Pipeline
Faisal Mohammad Amin
Department of Neurology, Danish Headache Center, Copenhagen University Hospital-Rigshospitalet, Glostrup, Denmark
Moderators
Moderator
Esme Ekizoğlu Turgut
İstanbul University, İstanbul Faculty of Medicine, Department of Neurology, İstanbul, Türkiye
Moderator
Doğa Vuralli
Gazi University Faculty of Medicine, Department of Neurology and Algology, NÖROM, Neuropsychiatric Center, Ankara, Türkiye
Organisers
Organised jointly by MENAA, the Global Migraine and Pain Society (GMPS) and NÖROM. Doktorclub hosts the live stream.
This webinar is intended for physicians and healthcare professionals. Content is educational and does not replace individual medical advice.